Why is Glaucoma Called the Secret Thief of Sight?
Glaucoma is one of the leading causes of blindness in adults who are 60 and older. You may have heard it called the “Secret Thief” or “Silent Thief” of sight. This is because many people develop glaucoma and don’t even know it until it’s too late. Glaucoma causes permanent damage to the optic nerve, which… Read More
If I Have Glaucoma, Do I Need Surgery?
Glaucoma is one of the most common age-related eye conditions. It’s also a leading cause of blindness in adults over 60. Often called The Silent Thief of Sight, glaucoma doesn’t present any symptoms in the early stages of the condition. Once it does cause visual symptoms, the damage to the eye is irreversible. That means… Read More
Are You at an Increased Risk of Developing Glaucoma?
Glaucoma is one of the most common eye conditions in the world. If left untreated, glaucoma can lead to irreversible vision loss. There is no cure for glaucoma, but treatment can significantly slow the disorder’s progress to decrease or prevent vision loss. Keep reading to learn if you may be at increased risk of developing… Read More
Why Does Glaucoma Cause Irreversible Vision Loss?
Glaucoma is one of the most common age-related eye conditions that you can develop. It’s also a leading cause of blindness in people over 60. Glaucoma is often referred to as the “silent thief of sight” because it’s hard to detect in the early stages. When most people notice vision loss from glaucoma, irreversible vision… Read More
January Is Glaucoma Awareness Month
If you couldn’t guess, January is National Glaucoma Awareness Month. With a nickname like the silent thief of sight, is it any wonder that it needs more awareness? Did you know that glaucoma is one of the leading causes of blindness for people who are sixty and older? It is the number one cause of… Read More
New treatment for Glaucoma available at NEEC
BOSTON, MA January 30, 2017 – New England Eye Center Glaucoma specialists are now offering a new minimally invasive surgical treatment for mild to moderate primary open-angle glaucoma. The CyPass Micro-Stent device was recently approved by the FDA for use in conjunction with cataract surgery. Research studies demonstrated a significant and lasting reduction in intraocular… Read More
Cynthia Mattox, MD Elected President of American Glaucoma Society
New England Eye Center Vice Chair of Clinical Services BOSTON, MA January 05, 2017 – New England Eye Center is proud to announce that Dr. Cynthia Mattox, Director of the Glaucoma and Cataract Service and Vice Chair of Clinical Services for New England Eye Center, has been elected as the President of the American Glaucoma… Read More